Sialix Receives $1,000,000 Series B Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    48 Wilde Road Newton, MA 02468
  • Company Description
    Sialix is developing products based on new biological discoveries of non-human sialic acids, their dietary role and inflammatory consequences, and their potential impact on cancer, cardiovascular, and other inflammatory-mediated diseases.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Boston Harbor Angels
  • Venture Investor
    Maine Angels
  • Venture Investor

Trending on Xconomy